75,117 Shares in HealthEquity, Inc. (NASDAQ:HQY) Acquired by Trexquant Investment LP

Trexquant Investment LP purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQYFree Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 75,117 shares of the company’s stock, valued at approximately $4,980,000.

Several other institutional investors also recently bought and sold shares of the company. Xponance Inc. increased its stake in HealthEquity by 1.2% during the 4th quarter. Xponance Inc. now owns 12,269 shares of the company’s stock worth $813,000 after buying an additional 147 shares in the last quarter. Fifth Third Bancorp lifted its stake in HealthEquity by 36.5% during the third quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock worth $44,000 after purchasing an additional 161 shares in the last quarter. KLR Investment Advisors LLC raised its stake in shares of HealthEquity by 4.2% in the fourth quarter. KLR Investment Advisors LLC now owns 5,914 shares of the company’s stock valued at $392,000 after acquiring an additional 241 shares in the last quarter. HighTower Advisors LLC increased its holdings in HealthEquity by 0.4% in the third quarter. HighTower Advisors LLC now owns 86,940 shares of the company’s stock valued at $6,366,000 after buying an additional 340 shares during the last quarter. Finally, Mariner LLC increased its holdings in HealthEquity by 2.4% in the third quarter. Mariner LLC now owns 14,983 shares of the company’s stock valued at $1,095,000 after buying an additional 345 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

HealthEquity Stock Up 0.2 %

HealthEquity stock opened at $79.46 on Thursday. The company has a market capitalization of $6.91 billion, a P/E ratio of 124.16, a P/E/G ratio of 1.16 and a beta of 0.55. The firm’s fifty day simple moving average is $79.86 and its 200-day simple moving average is $75.30. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.43. HealthEquity, Inc. has a 1-year low of $54.09 and a 1-year high of $84.49.

HealthEquity (NASDAQ:HQYGet Free Report) last announced its earnings results on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.42 by $0.08. The firm had revenue of $262.39 million for the quarter, compared to the consensus estimate of $258.56 million. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. Sell-side analysts forecast that HealthEquity, Inc. will post 2.12 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Jon Kessler sold 33,765 shares of HealthEquity stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the sale, the chief executive officer now directly owns 126,635 shares in the company, valued at approximately $10,106,739.35. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, EVP Delano Ladd sold 2,558 shares of the company’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $82.59, for a total value of $211,265.22. Following the completion of the transaction, the executive vice president now owns 47,438 shares in the company, valued at $3,917,904.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jon Kessler sold 33,765 shares of the stock in a transaction on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the transaction, the chief executive officer now owns 126,635 shares of the company’s stock, valued at approximately $10,106,739.35. The disclosure for this sale can be found here. Insiders have sold 68,823 shares of company stock worth $5,482,975 in the last ninety days. Insiders own 2.70% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have issued reports on HQY. Barrington Research reaffirmed an “outperform” rating and set a $100.00 price objective on shares of HealthEquity in a report on Friday, March 22nd. Barclays upped their price objective on HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a report on Friday, February 23rd. Bank of America upped their price target on shares of HealthEquity from $93.00 to $97.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Royal Bank of Canada upped their price objective on shares of HealthEquity from $90.00 to $92.00 and gave the company an “outperform” rating in a research report on Wednesday, March 20th. Finally, KeyCorp raised their price target on shares of HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, March 22nd. One equities research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $96.17.

Get Our Latest Research Report on HQY

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Stories

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYFree Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.